Frøya, Norway, 5 June 2025: Reference is made to the stock exchange announcement made by Kaldvík AS ("Kaldvík" or the "Company") earlier today (the "Announcement"), regarding the successful completion of a private placement (the "Private Placement") of new shares in the Company raising gross proceeds of approximately NOK 532 million, equal to approximately EUR 46.2 million. In connection with the Private Placement, the following transactions have been made by close associates of the Company's primary inside ...

HRC World Plc (the "Company") wishes to announce the following changes to its Board of Directors, including resignation and re-designation as approved and resolved by the Board, effective 5 June 2025: The Board of Directors would like to express its sincere appreciation to Mr. Gajera for his invaluable contributions and dedicated service during his tenure on the Board. His leadership, insight, and commitment have played an important role in supporting the Company's strategic direction and growth. The Board ...

CMND-100 has the potential to provide an innovative and advanced treatment option for hundreds of millions of people around the world afflicted with Alcohol Use Disorder Vancouver, Canada, June 05, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced the enrollment of the first pa ...

Four presentations on MET-097i, a fully biased, monthly, ultra-long acting GLP-1 receptor agonist, including two clinical data presentations Additional preclinical presentations on other differentiated portfolio assets, including MET-233i, a monthly, ultra-long acting amylin analog NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (Nasdaq: MTSR), a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, will highlight the breadth and ...

Interested in attending or participating remotely: NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to developing medicines for brain conditions with significant unmet need, will host an investor and media event on Thursday, June 12, 2025, on the topic of applying Biomarkers in Epilepsy, including their strategic use to demonstrate the pharmacodynamic activity of the Company's OV329 clinical development program. World-leading expert, Dr ...

TORONTO, June 05, 2025 (GLOBE NEWSWIRE) -- Global diversified professional services and investment management company, Colliers (NASDAQ, TSX: CIGI), announced today it has completed its previously announced acquisition of Triovest Inc. (“Triovest”), a leading Canadian commercial real estate services platform. The acquisition solidifies Colliers’ position as Canada’s largest commercial real estate services firm, employing more than 3,000 professionals, managing more than 95 million square feet of commercial ...

AI-driven BSS recognized for empowering MVNEs and MVNOs to launch and configure eSIM enablement and advanced product catalogs at speedTORONTO, June 05, 2025 (GLOBE NEWSWIRE) -- Optiva Inc. (TSX: OPT), a leader in powering the telecom industry with cloud-native billing, charging and revenue management software on private and public clouds, is honored to receive the MVNOs World award for AI & Analytics Excellence. Optiva BSS Platform, featuring integrated AI-agents, was recognized for providing digital-first ...

Fredericton, New Brunswick, June 05, 2025 (GLOBE NEWSWIRE) -- NextGen Digital Platforms Inc. (CSE:NXT) (OTCQB:NXTDF) (FSE:Z12) (“NextGen” or the “Company”) is pleased to announce that it has expanded its fleet of computing workstations for its online hardware-as-a-service business (“Cloud AI Hosting”) and that the newly acquired workstations have begun generating revenue. The three new workstations, each equipped with a high-performance Nvidia graphics processing unit (“GPU”), bring the Company’s total a ...

Core Insights - Dyne Therapeutics announced new preclinical data for DYNE-302, showing potential functional improvement in facioscapulohumeral muscular dystrophy (FSHD) [1][2] - The data will be presented at the 32nd Annual FSHD Society's International Research Congress in Amsterdam on June 12-13, 2025 [1][4] Company Overview - Dyne Therapeutics is focused on developing therapeutics for genetically driven neuromuscular diseases, leveraging its FORCE™ platform [6] - The company has a broad pipeline that includes clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD), as well as preclinical programs for FSHD and Pompe disease [6] Disease Background - FSHD is a rare, progressive genetic disease caused by a mutation in the DUX4 gene, leading to muscle loss and weakness [5] - An estimated 16,000 to 38,000 individuals in the U.S. and approximately 35,000 in Europe are affected by FSHD, with no approved therapies currently available [5] Research Findings - In a mouse model of severe FSHD, a single intravenous dose of DYNE-302 restored the ability to run on a treadmill, indicating potential reversal of muscle damage and inflammation [2][3] - DYNE-302 targets DUX4 mRNA to suppress its expression, aiming to address the underlying cause of muscle damage in FSHD [3] Presentation Details - The oral presentation on DYNE-302's effects will take place on June 13, 2025, at 12:00 p.m. CEST [4] - The presentation will be available on Dyne's website following the session [4]

Event Recognizes Bowman’s Journey from Local Firm to National Engineering PartnerRESTON, Va., June 05, 2025 (GLOBE NEWSWIRE) -- Bowman Consulting Group Ltd. (NASDAQ: BWMN), a national engineering services and program management firm, will ring the Nasdaq Stock Market opening bell on June 9, 2025, commemorating its 30th anniversary. Founder and CEO, Gary Bowman, alongside members of the Company’s leadership team and employees, will participate in the ceremonial bell ringing at the Nasdaq MarketSite in Times ...